Page 64 - Michael Erman News Today

By Michael Erman NEW YORK (Reuters) - All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detecte...

By Michael Erman
NEW YORK (Reuters) - All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detected Omicron variant of the coronavirus in laboratory testing, but a booster dose likely restores most of the protection, according to a study released o...

By Michael Erman NEW YORK (Reuters) - All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detecte...

NEW YORK, Dec 14 (Reuters) - Pfizer Inc (PFE.N) on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus. The U.S. drugmaker...

By Michael Erman

By Michael Erman and Deena Beasley

NEW YORK (Reuters) -Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.

NEW YORK -Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug...

At the current pace, fewer than half of U.S. children ages 5 to 11 are expected to be fully vaccinated in the coming months, state officials told Reuters. Some states, including Mississippi, said thousands of vaccine doses are sitting idle.

Arrival of the highly-mutated Omicron variant is a wake-up call to develop vaccines less susceptible to the rapid changes of the coronavirus, leading virologists and immunologists told Reuters.